InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Baynes Roy D., Director. Insider active across 4 companies, notably Travere Therapeutics, Inc.. Aggregated, 47 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.4m. History available since 14 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Baynes Roy D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
1,571 sharesCommon StockSEC:0001680739-26-000015:0
75 sharesCommon StockSEC:0001680739-26-000015:1
4,500 sharesCommon StockSEC:0001680739-26-000014:0
4,500 sharesCommon StockSEC:0001680739-26-000014:1
4,000 shares0Common StockSEC:0001680739-26-000012:0
83 sharesCommon StockSEC:0001680739-26-000006:0
8,000 shares@ US$17.940.0026% mcap4.7% of flowCommon StockSEC:0001680739-26-000005:0
9,000 shares@ US$15.430.0025% mcap4.5% of flowCommon StockSEC:0001680739-26-000005:1
4,500 shares@ US$18.270.0015% mcap2.7% of flowCommon StockSEC:0001680739-26-000005:2
4,500 shares@ US$21.380.0017% mcap3.2% of flowCommon StockSEC:0001680739-26-000005:3
6,750 shares@ US$17.110.0021% mcap3.8% of flowCommon StockSEC:0001680739-26-000005:4
26,000 shares@ US$41.070.019% mcap35.0% of flowCommon StockSEC:0001680739-26-000005:5
6,750 shares@ US$42.120.0051% mcap9.3% of flowCommon StockSEC:0001680739-26-000005:6
10,000 shares@ US$26.520.0058% mcap24.1% of flowCommon StockSEC:0001680739-26-000003:0
10,000 shares@ US$33.000.0072% mcap30.0% of flowCommon StockSEC:0001680739-26-000003:1
70 sharesCommon StockSEC:0001680739-26-000001:0
5,112 shares@ US$40.9324.7% of flowCommon StockSEC:0001680739-25-000007:0
93 sharesCommon StockSEC:0001680739-25-000005:0
108 sharesCommon StockSEC:0001415889-25-020514:0
2,143 sharesCommon StockSEC:0001415889-25-018834:0
6,500 shares0Common StockSEC:0001415889-25-013496:0
116 sharesCommon StockSEC:0001415889-25-011550:0
10,000 shares@ US$17.4417.6% of flowCommon StockSEC:0001415889-25-003529:0
92 sharesCommon StockSEC:0001415889-25-003068:0
16,000 shares@ US$17.5028.2% of flowCommon StockSEC:0001415889-25-002003:0
25 of 47 declarations
About Baynes Roy D.
Baynes Roy D. is an Administrateur at Natera, Inc., Travere Therapeutics, Inc. and Atara Biotherapeutics, Inc. The declarant has 47 filings in total, and across the sampled recent filings from 2021-05-18 to 2026-06-30, the aggregated amounts show €0 of buys and €1,431,862 of sells, with the modal transaction nature listed as Attribution.
